Metabolomic and lipidomic signatures in autosomal dominant and late‐onset Alzheimer's disease brains
Alzheimer's & Dementia · 2023-05 · 19 (5) · 1785-1799
DOI: 10.1002/alz.12800 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 17.10.2022. Verfasst von Brenna C Novotny und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Introduction
The identification of multiple genetic risk factors for Alzheimer's disease (AD) suggests that many pathways contribute to AD onset and progression. However, the metabolomic and lipidomic profiles in carriers of distinct genetic risk factors are not fully understood. The metabolome can provide a direct image of dysregulated pathways in the brain.
Methods
We interrogated metabolomic signatures in the AD brain, including carriers of pathogenic variants in APP , PSEN1 , and PSEN2 (autosomal dominant AD; ADAD), APOE ɛ4, and TREM2 risk variant carriers, and sporadic AD (sAD).
Results
We identified 133 unique and shared metabolites associated with ADAD, TREM2, and sAD. We identified a signature of 16 metabolites significantly altered between groups and associated with AD duration.
Discussion
AD genetic variants show distinct metabolic perturbations. Investigation of these metabolites may provide greater insight into the etiology of AD and its impact on clinical presentation. HIGHLIGHTS APP / PSEN1 / PSEN2 and TREM2 variant carriers show distinct metabolic changes. A total of 133 metabolites were differentially abundant in AD genetic groups. β‐citrylglutamate is differentially abundant in autosomal dominant, TREM2 , and sporadic AD. A 16‐metabolite profile shows differences between Alzheimer's disease (AD) genetic groups. The identified metabolic profile is associated with duration of disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA.
- Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri, USA.
- NeuroGenomics and Informatics Center, Washington University School of Medicine, St. Louis, Missouri, USA.
- Division of Biology & Biomedical Sciences, Washington University in St. Louis, St. Louis, Missouri, USA.
- The Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, Missouri, USA.
- Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
ORCID-Profile: Brenna C Novotny, Maria Victoria Fernandez, Ciyang Wang, John P Budde, Abdallah M Eteleeb, Umber Dube, Fengxian Wang, John C Morris, Randall J Bateman, Eric McDade, Jasmeer Chhatwal, Alison Goate, Peter Schofield, Celeste M Karch, Carlos Cruchaga, Bruno A Benitez, Oscar Harari
Förderung
- NIA NIH HHS
- NINDS NIH HHS
Zitieren
APA
Novotny, B. C., Fernandez, M. V., Wang, C., Budde, J. P., Bergmann, K., Eteleeb, A. M., Bradley, J., Webster, C., Ebl, C., Norton, J., Gentsch, J., Dube, U., Wang, F., Morris, J. C., Bateman, R. J., Perrin, R. J., McDade, E., Xiong, C., Chhatwal, J., …, & Harari, O. (2023). Metabolomic and lipidomic signatures in autosomal dominant and late‐onset Alzheimer's disease brains. Alzheimer's & Dementia, 19(5), 1785-1799. https://doi.org/10.1002/alz.12800
Vancouver
Novotny BC, Fernandez MV, Wang C, Budde JP, Bergmann K, Eteleeb AM, et al. Metabolomic and lipidomic signatures in autosomal dominant and late‐onset Alzheimer's disease brains. Alzheimer's & Dementia. 2023;19(5):1785-1799. doi:10.1002/alz.12800
BibTeX
@article{Novotny2023,
author = {Novotny, Brenna C and Fernandez, Maria Victoria and Wang, Ciyang and Budde, John P and Bergmann, Kristy and Eteleeb, Abdallah M and Bradley, Joseph and Webster, Carol and Ebl, Curtis and Norton, Joanne and Gentsch, Jen and Dube, Umber and Wang, Fengxian and Morris, John C and Bateman, Randall J and Perrin, Richard J and McDade, Eric and Xiong, Chengjie and Chhatwal, Jasmeer and Dominantly Inherited Alzheimer Network (DIAN) Study Group, Dominantly Inherited Alzheimer Network (DIAN) Study Group and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative and Alzheimer's Disease Metabolomics Consortium (ADMC), Alzheimer's Disease Metabolomics Consortium (ADMC) and Goate, Alison and Farlow, Martin and Schofield, Peter and Chui, Helena and Karch, Celeste M and Cruchaga, Carlos and Benitez, Bruno A and Harari, Oscar},
title = {Metabolomic and lipidomic signatures in autosomal dominant and late‐onset Alzheimer's disease brains},
journal = {Alzheimer's & Dementia},
year = {2023},
volume = {19},
number = {5},
pages = {1785--1799},
doi = {10.1002/alz.12800}
}
EUVIMED